Advertisement

Mo1667 FECAL MICROBIOTA TRANSPLANTATION FOR CHILDREN WITH AUTISM SPECTRUM DISORDER

      Autism spectrum disorders (ASD), with impaired social communication and interactions, restricted, repetitive patterns of behavior/interests/activities, are developmental disability without fully understood etiologies and specific treatment. Previous studies showed increased gastrointestinal(GI) problems and intestinal dysbiosis in patients with ASD. Modulating gut microbiome could alleviate ASD-related behaviors and GI symptoms, but the efficacy of fecal microbiota transplantation (FMT) in ASD is unknown. Here, we conducted an open-label, randomized waitlist-controlled trial to assess the efficacy and safety of FMT for patients with ASD.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect